About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT02893046

HCV Care Pathway in Ile-de-France

The main objective of this research is to evaluate a care pathway adapted to different category populations at risk of being infected with the hepatitis C virus in order to improve both the diagnosis ...

Lead sponsor: Assistance Publique - Hôpitaux de Paris•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Stéphanie DOMINGUEZ, MD

CONTACT

(0)1 49 81 25 26 stephanie.dominguez@aphp.fr

Antoine BACHELARD, MD

CONTACT

(0)1 49 81 25 26 antoine.bachelard2@aphp.fr

Sponsors

Lead Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

Agence Regionale de Sante d'Ile de France

The current estimation of infected persons with chronic hepatitis C in France is over 200 ,000. It appears that prevention, screening, care management, medical and social care of patients can be significantly improved especially among the most vulnerable populations. Indeed, these new HCV infections are mediated by drug-using people, prisoners, migrants, men who have sex with men (MSM) and who are supported too late and without real access to treatment.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•18 years old and more
•Positive Hepatitis C virus
•Patient having expressed a non-objection to participate in this research

Related studies

Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening

NCT06745895 · Colorectal Cancer Screening, Hepatitis C Virus

Characterization of Immune Genotypes and Antibody Profiles to Foster the discoVERY of diagnosticbioMARKERS of Liver Cancer Development

NCT06718530 · Hepatitis C Virus Infection

Screening for Hepatitis c in People Who Inject Drugs in Armenia-Colombia

NCT06463912 · Hepatitis C Virus Infection

Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures

NCT05361603 · Hepatitis C, Transmission, Intravenous Drug Abuser, and more

Active Not RecruitingPhase 3

C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV

NCT06868264 · HEPATITIS C VIRUS CHRONIC INFECTION

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 8, 2016Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment1,000

Start dateSep 2016

Last updatedSep 8, 2016

Condition

Hepatitis C Virus

Locations shown

Henri Mondor Hospital

Créteil

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 8, 2016Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions